Adoptive Transfer of Regulatory T Cells as a Way to Treat Atherosclerosis
In conclusion, a number of studies have shown that CD4+ Treg cells are crucial in the maintenance of peripheral tolerance and have an important role in the control of atherosclerosis-related inflammation. Therefore, Treg cells are a promising target of major research efforts focused on immune-modulating therapies against atherosclerosis. Developing anti-atherosclerotic Treg-based therapies faces challenges. However, rapid progress in genetic, epigenetic, and molecular aspects of cellular immunology gives hope for a fast-track solution.
Source: Fight Aging! - Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
More News: Academia | Allergy & Immunology | Autoimmune Disease | Biotechnology | Cancer | Cancer & Oncology | Cardiology | Cholesterol | Environmental Health | Genetics | Heart | Heart Attack | Heart Failure | Immunotherapy | Research | Statin Therapy | Stroke | Study | Toxicology